Showing 151-160 of 20874 results for "".
Treatment Decisions That Matter: Live Tumor Board in Advanced Ovarian Cancer
https://reachmd.com/live-events/treatment-decisions-that-matter-live-tumor-board-in-advanced-ovarian-cancer/57215/Join a live webinar exploring biomarker-driven treatment decisions in advanced ovarian cancer, from molecular testing and therapy selection to AE management.Location: OnlineDate: September 3, 2026; 02:00 PM - 03:00 PM ETPush Past in AD: Treatment Escalation in Moderate to Severe Atopic Dermatitis
https://reachmd.com/live-events/push-past-in-ad-treatment-escalation-in-moderate-to-severe-atopic-dermatitis/57115/Learn how to assess atopic dermatitis severity and apply guideline-aligned strategies to optimize treatment selection for moderate to severe disease.Location: OnlineDate: November 12, 2026; 12:00 PM - 01:00 PM ETTargeting TROP2 in EGFR-Mutated Advanced NSCLC: Navigating the ADC Revolution After TKI Failure
https://reachmd.com/live-events/targeting-trop2-in-egfr-mutated-advanced-nsclc-navigating-the-adc-revolution-after-tki-failure/60661/Explore the roles of TROP2-directed ADCs in EGFR-mutated advanced NSCLC after TKI failure, with practical guidance on patient selection and toxicity management.Location: OnlineDate: September 16, 2026; 08:00 AM - 08:30 AM EDTTargeting TROP2 in EGFR-Mutated Advanced NSCLC: Navigating the ADC Revolution After TKI Failure
https://reachmd.com/live-events/targeting-trop2-in-egfr-mutated-advanced-nsclc-navigating-the-adc-revolution-after-tki-failure/60663/Explore the roles of TROP2-directed ADCs in EGFR-mutated advanced NSCLC after TKI failure, with practical guidance on patient selection and toxicity management.Location: OnlineDate: September 30, 2026; 08:00 PM - 08:30 PM EDTTargeting TROP2 in EGFR-Mutated Advanced NSCLC: Navigating the ADC Revolution After TKI Failure
https://reachmd.com/live-events/targeting-trop2-in-egfr-mutated-advanced-nsclc-navigating-the-adc-revolution-after-tki-failure/60662/Explore the roles of TROP2-directed ADCs in EGFR-mutated advanced NSCLC after TKI failure, with practical guidance on patient selection and toxicity management.Location: OnlineDate: September 23, 2026; 12:00 PM - 12:30 PM EDT- Spotlight on Type 1 Diabetes - Programshttps://reachmd.com/programs/spotlight-t1d/
- Practical Dermatology: Type II Inflammation Journal Club - Programshttps://reachmd.com/programs/practical-dermatology-type-ii-inflammation-journal-club/
- Diabetes and Endocrinology - Industry Featurehttps://reachmd.com/industry-feature/diabetes-and-endocrinology/
- Diabetes - CMEhttps://reachmd.com/cme/diabetes/
- Diabetes Discourse - Programshttps://reachmd.com/programs/diabetes-discourse/